Multiple Sclerosis Clinical Trials in New York

Showing 681-700 of 812 trials

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

NCT01260168

The objective of this study is to confirm the sensitivity of a stool DNA test for detection of colorectal cancer and pre-cancer. Another objective is to provide anonymous, clinically characterized specimens for a bio-repository for future colorectal cancer-related test development.

Colorectal NeoplasmsDigestive System DiseasesColonic Diseases+1 more

Exact Sciences Corporation435 participantsStarted Oct 2010

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Atlanta, Georgia, United States +18 more locations

COMPLETEDPhase 2< 1 mile

Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors

NCT00831844

This phase II trial is studying the side effects and how well cixutumumab works in treating patients with relapsed or refractory solid tumors. Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them.

Adult RhabdomyosarcomaAdult Synovial SarcomaChildhood Hepatoblastoma+13 more

National Cancer Institute (NCI)116 participantsStarted Jan 2009

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Downey, California, United States +102 more locations

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors

Multiple Sclerosis Trials in Other Cities

Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer

iCAT for Recurrent/Refractory/HR Solid Tumors

Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer

Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer

Will a Real Time Advisory for Double Low State Change Clinical Behavior and Impact Outcomes

Natalizumab High Titer Immunogenicity and Safety

Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia

A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis

Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis

A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis

Mindfulness Based Stress Reduction in Multiple Sclerosis (MS)

Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis

Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects

Sorafenib/ Carboplatin/ Paclitaxel in Patients With Solid Tumors

NP2 Enkephalin For Treatment of Intractable Cancer Pain

An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis

MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer

Other Conditions in New York